Cargando…
CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607013/ https://www.ncbi.nlm.nih.gov/pubmed/34788929 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.10.013 |
| _version_ | 1784602461495885824 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8607013 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86070132021-11-22 CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2021-10 /pmc/articles/PMC8607013/ /pubmed/34788929 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.10.013 Text en 2021年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 短篇论著 CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性 |
| title | CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性 |
| title_full | CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性 |
| title_fullStr | CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性 |
| title_full_unstemmed | CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性 |
| title_short | CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性 |
| title_sort | cmv-ctl治疗替代供者造血干细胞移植后复发难治性cmv感染17例疗效及安全性 |
| topic | 短篇论著 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607013/ https://www.ncbi.nlm.nih.gov/pubmed/34788929 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.10.013 |
| work_keys_str_mv | AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng AT cmvctlzhìliáotìdàigōngzhězàoxuègànxìbāoyízhíhòufùfānánzhìxìngcmvgǎnrǎn17lìliáoxiàojíānquánxìng |